tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

HBM Holdings Projects Significant Profit Growth for First Half of 2025

Story Highlights
HBM Holdings Projects Significant Profit Growth for First Half of 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

HBM Holdings Ltd. ( (HK:2142) ) has issued an update.

HBM Holdings Ltd. has issued a positive profit alert, anticipating a significant profit increase for the first half of 2025, ranging between approximately US$68 million to US$74 million. This growth is primarily driven by strategic collaborations, including a partnership with AstraZeneca, and successful out-licensing and business development activities that have contributed to a stable revenue stream.

More about HBM Holdings Ltd.

HBM Holdings Ltd. is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. It focuses on strategic partnerships and collaborations with global pharmaceutical companies, such as AstraZeneca, and engages in out-licensing and development of innovative products.

Average Trading Volume: 9,816,649

Technical Sentiment Signal: Buy

Current Market Cap: HK$8.03B

Learn more about 2142 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1